Immix Biopharma, Inc. IMMX Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s convertible preferred stock outstanding shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s convertible preferred stock outstanding shares?
- Immix Biopharma, Inc. (IMMX) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
- What does convertible preferred stock outstanding shares mean?
- This represents the total number of preferred equity shares that carry the right to be converted into common stock at a specified ratio. For investors, this metric is critical for calculating fully diluted share counts and understanding potential future equity dilution. It reflects the company's historical reliance on hybrid capital structures.